Michael Adler
Obstetrics & Gynecology · Houston, TXNPI 1639408933
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 183 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations.
Across 183 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$593
- Evofem Biosciences, Inc.$381
- Bayer$296
- Biogen$262
- Pfizer$220
- Mayne Pharma Commercial LLC$200
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,46098%
- Education$772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $593 |
| Evofem Biosciences, Inc. | 21 | $381 |
| Bayer | 13 | $296 |
| Biogen | 10 | $262 |
| Pfizer | 14 | $220 |
| Mayne Pharma Commercial LLC | 10 | $200 |
| Sumitomo Pharma America, Inc. | 8 | $179 |
| Medtronic | 3 | $145 |
| Hologic Sales And Service, LLC | 5 | $127 |
| Exeltis, USA Inc. | 9 | $126 |
| Therapeuticsmd, Inc. | 8 | $123 |
| Baxter Healthcare | 2 | $95 |
| Avion Pharmaceuticals | 5 | $86 |
| Merck | 5 | $78 |
| Abbott | 4 | $66 |
| Gynesonics, Inc. | 2 | $63 |
| AMAG Pharmaceuticals, Inc. | 3 | $54 |
| Millicent US Inc | 3 | $53 |
| Coopersurgical, Inc. | 3 | $47 |
| Johnson & Johnson(2 entities) | 2 | $46 |
| Amgen | 2 | $38 |
| Organon | 8 | $31 |
| Renovia Inc | 2 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| Myovant Sciences Inc. | 1 | $23 |
| Smith+Nephew | 1 | $23 |
| Mylan Pharmaceuticals Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Mission Pharmacal Company | 1 | $18 |
| Ascend Therapeutics US, LLC | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Medicem Inc. | 1 | $14 |
| Covidien LP | 1 | $14 |
How this compares
$3,537 in reported general payments places this provider in the 75th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in Houston
- George KuhnHouston$244K
- Daisy AyimHouston$188K
- Shannon WestinHouston$176K
- Asha BhalwalHouston$151K
- Nicole TranHouston$133K
- Sandra HurtadoHouston$123K
- Alvaro MontealegreHouston$92K
- Patti RossHouston$72K
- Damla KarsanHouston$58K
- Christopher JayneHouston$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.